drugset / Trial / NCT03315910
Implementing Tobacco Treatment in Low Dose CT Lung Cancer Screening Sites
Phase 4
Active not recruiting
807 enrolled
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI) · collab
RandomizedFactorialOpen-labelPrevention
Summary
This study is to help determine the most effective type or combination of treatments to offer patients seeking lung cancer screening who are smokers to help them reduce the number of cigarettes they smoke, or quit smoking. The investigators long term goal is to increase the benefits of lung cancer screening by providing a blue print of best practices for screening sites to deliver tobacco treatment to their patients who are smokers, in a way that does not add burden to screening site staff and increases the chances of patients quitting smoking.
Timeline
- Start
- 2017-10-10
- Primary completion
- 2026-10
- Completion
- 2026-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nicotine | Unknown | 2 mg | — |
| Subject | Nicotine | Unknown | 14 mg | Other |
| Subject | Nicotine | Unknown | 21 mg | Other |
Indications
No indication recorded.